Literature DB >> 11989572

Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.

K Ivens1, F Gradaus, P Heering, F C Schoebel, M Klein, H D Schulte, B E Strauer, B Grabensee.   

Abstract

BACKGROUND: Ischemic heart disease is the major cause of death in patients with end-stage renal disease. The high prevalence of coronary artery disease results in a rising number of dialysis patients requiring myocardial revascularisation.
OBJECTIVE: The objective of this study was to compare the outcomes of recurrent angina, myocardial infarction, rate of reinterventions and cardiovascular death following percutaneous coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) in patients with end-stage renal disease. PATIENTS AND METHODS: In a retrospective investigation 40 patients with chronic renal failure undergoing primarily PTCA and 65 patients undergoing CABG were included. Both groups were comparable for gender, duration on dialysis and the number of cardiovascular risk factors per patient. Patients undergoing PTCA were younger (53 +/- 12 years vs. 57 + 8 years; p < 0.05) and more often diabetics (30% vs. 14%; p < 0.05).
RESULTS: Most patients in both groups had a multi-vessel disease (95% in the CABG group vs. 74% in the PTCA group), in the CABG group there were significantly more patients with a triple-vessel disease (62% with vs. 40% in the PTCA group; p < 0.01), PTCA was primarily successful in 95% of the patients while complete revascularization was achieved in 88% of patients undergoing CABG. The perioperative mortality after CABG was 4.8% as compared to none after interventional revascularisation. The cumulative freedom of angina after 6, 12 and 24 months after intervention was significantly lower after PTCA (54%, 40%, 29%) than after bypass grafting (97%, 94%, 90%, p < 0.001). The frequency of reinterventions following PTCA was significantly higher compared to patients following CABG (p < 0.001). After PTCA 15 patients needed further revascularisations, 8 of them underwent CABG, whereas after CABG only two patients required additional myocardial revascularisation. There was no significant difference in the overall mortality between both groups; the survival rate after 12 and 24 months was 95% and 82% after PTCA and 93% and 86% after CABG, respectively. CONDITION: Although patients receiving CABG had a more severe coronary artery disease the overall mortality was comparable and clinical and functional outcome was improved compared to patients after coronary angioplasty.

Entities:  

Mesh:

Year:  2001        PMID: 11989572     DOI: 10.1023/a:1015067611958

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

Review 1.  Lipid abnormalities in renal disease.

Authors:  G Appel
Journal:  Kidney Int       Date:  1991-01       Impact factor: 10.612

2.  [Cardiosurgical therapy of coronary heart disease in terminal kidney insufficiency].

Authors:  K Ivens; P Heering; M Leschke; B Strauer; M Klein; H D Schulte; B Grabensee
Journal:  Dtsch Med Wochenschr       Date:  1996-06-14       Impact factor: 0.628

3.  Results of coronary artery bypass grafting in end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; A D Pacifico
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

4.  Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.

Authors:  D Mezzano; R Tagle; O Panes; M Pérez; P Downey; B Muñoz; E Aranda; P Barja; S Thambo; F González; S Mezzano; J Pereira
Journal:  Thromb Haemost       Date:  1996-09       Impact factor: 5.249

5.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; N J Lembo; W S Weintraub; A S Kosinski; H X Barnhart; M H Kutner; N P Alazraki; R A Guyton; X Q Zhao
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

6.  Intraoperative versus routine hemodialysis in end-stage renal disease patients undergoing open-heart surgery.

Authors:  B E Ilson; P S Bland; D K Jorkasky; N Shusterman; N L Allison; J W Dubb; G V Parr; T K Goebel; R M Stote
Journal:  Nephron       Date:  1992       Impact factor: 2.847

7.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

8.  Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.

Authors:  F C Schoebel; F Gradaus; K Ivens; P Heering; T W Jax; B Grabensee; B E Strauer; M Leschke
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

9.  Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study.

Authors:  R Kornowski; G S Mintz; K M Kent; A D Pichard; L F Satler; T A Bucher; M K Hong; J J Popma; M B Leon
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

10.  Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival.

Authors:  J A Opsahl; D G Husebye; H K Helseth; A J Collins
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

View more
  12 in total

Review 1.  The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.

Authors:  Stephen A May; James M Wilson
Journal:  Tex Heart Inst J       Date:  2009

2.  Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.

Authors:  Tara I Chang; David Shilane; Dhruv S Kazi; Maria E Montez-Rath; Mark A Hlatky; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2012-12       Impact factor: 10.121

3.  [Heart and kidneys].

Authors:  D Kiski; H Reinecke
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

Review 4.  Revascularization options in patients with chronic kidney disease.

Authors:  Guha Ashrith; MacArthur A Elayda; James M Wilson
Journal:  Tex Heart Inst J       Date:  2010

Review 5.  Optimal method of coronary revascularization in patients receiving dialysis: systematic review.

Authors:  Immaculate F Nevis; Anna Mathew; Richard J Novick; Chirag R Parikh; Philip J Devereaux; Madhu K Natarajan; Arthur V Iansavichus; Meaghan S Cuerden; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

6.  Coronary artery bypass grafting in patients on maintenance dialysis: is peritoneal dialysis a risk factor of operative mortality?

Authors:  Hui Zhong; Tirone David; Ai Hua Zhang; Wei Fang; Mufazzal Ahmad; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-12-02       Impact factor: 2.370

7.  Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA.

Authors:  Dipen S Parikh; Madhav Swaminathan; Laura E Archer; Jula K Inrig; Lynda A Szczech; Andrew D Shaw; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2010-01-26       Impact factor: 5.992

8.  The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography.

Authors:  Ki Young Na; Chi Weon Kim; Young Rim Song; Ho Joon Chin; Dong-Wan Chae
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

9.  Optimal treatment strategies for coronary artery disease in patients with advanced kidney disease: a meta-analysis.

Authors:  Jingwen Yong; Jinfan Tian; Xin Zhao; Xueyao Yang; Haoran Xing; Yi He; Xiantao Song
Journal:  Ther Adv Chronic Dis       Date:  2021-07-07       Impact factor: 5.091

10.  Revascularisation of patients with end-stage renal disease on chronic haemodialysis: bypass surgery versus PCI-analysis of routine statutory health insurance data.

Authors:  Martin Möckel; Julia Searle; Henning Thomas Baberg; Peter Dirschedl; Benny Levenson; Jürgen Malzahn; Thomas Mansky; Christian Günster; Elke Jeschke
Journal:  Open Heart       Date:  2016-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.